Mounjaro Injection for Diabetes: What Patients Should Know
Home Mounjaro Injection for Diabetes: What Patients Should Know
Mounjaro (tirzepatide) is a once-weekly prescription injection for eligible people with type 2 diabetes to help control their blood sugar levels. It acts on GIP and GLP-1 receptors, and requires suitable medical care. Control of diabetes type 2 is not just about a single sugar measurement. A treatment that’s getting a lot of attention is for diabetes, Mounjaro injection. It contains the active ingredient, tirzepatide, which acts on two hormone pathways that help control blood glucose.
What is Mounjaro Injection?
Mounjaro is the brand name for tirzepatide, a prescription drug which works by stimulating the GIP and GLP-1 receptors to help control the blood sugar levels of individuals with type 2 diabetes.
Tirzepatide works on glucagon-like peptide-1 (GLP-1) receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors, unlike other medications that only act on the GLP-1 receptor. Mounjaro is not a diabetes treatment; it is meant to be used in addition to and not in place of, proper nutrition, physical activity, glucose monitoring, and diabetes care.
| Mounjaro Overview | Key Information |
| Active ingredient | Tirzepatide |
| Medication Sessions | GIP/GLP-1 receptor agonist |
| Used | Subcutaneous injection |
| Frequency | Once weekly |
| Primary purpose | Improve glycemic control in type 2 diabetes |
| Prescription required | Yes |
| Medical monitoring | Recommended |
What Does Mounjaro Do for Type 2 Diabetes?
Mounjaro stimulates GIP and GLP-1 receptors to help control glucose dependent insulin secretion and other functions relating to blood sugar control. Type 2 diabetes occurs when the body doesn’t use insulin properly, or it doesn’t make enough insulin to keep glucose levels normal.
Tirzepatide targets multiple metabolic pathways. It can cause:
- Increasing glucose-dependent insulin secretion.
- Decreasing the release of glucagon when it is not needed.
- Slowing gastric emptying.
- Increasing appetite and eating.
- Assisting better glucose control.
However, every patient responds differently. Treatment decisions may be affected by blood glucose, HbA1c, current medications, medical history, kidney function, gastrointestinal health and more.
Advantages of Mounjaro for Diabetes
When combined with diet, exercise, and continuing medical management, Mounjaro can be a useful treatment to help improve HbA1c and fasting blood glucose in appropriate patients.
Tirzepatide has been clinically shown to have significant effects on lowering HbA1c in adults with type 2 diabetes. The possible advantages of treatment include:
- Improved overall blood sugar control.
- Lower HbA1c levels.
- Once-weekly administration.
- Improved fasting glucose.
- Some patients have decreased appetite.
- Some people with type 2 diabetes lose weight.
Weight changes are not guaranteed, and are highly variable from person to person. Patients should also be aware that Mounjaro’s diabetes signs and weight management treatment are not the same thing. Any treatment should always be recommended based on the patient’s clinical needs and not on what is trending in social media or what the patient expects.
Mounjaro Dosage At Enfield Royal Clinic Islamabad
Usually treatment starts on a low dose and is slowly increased as directed on the label and depending on how the patient responds to the treatment.
The usual starting dose to take if you are an adult is 2.5 mg once a week for four weeks, then 5 mg once a week. If more glycemic control is needed, the dose can be increased every 2.5 mg for at least 4 weeks.
| Treatment Stage | Adult Dose |
| Starting dose | 2.5 mg once weekly |
| After 4 weeks | 5 mg once weekly |
| Further adjustment | 2.5 mg increments when appropriate |
| Maximum adult dose | 15 mg once weekly |
The 2.5 mg starting dose is to initiate treatment but not for glycemic control.
What Are The Common Side Effects of Mounjaro?
The most common Mounjaro side effects are stomach-related such as constipation, stomach pain, indigestion, diarrhea, nausea, decreased appetite, and vomiting.
Digestive symptoms may be more noticeable when treatment begins or following dose escalation. The most frequent side effects are:
- Nausea
- Diarrhea
- Reduced appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
What Serious Mounjaro Risks Should Patients Understand?
Short Answer: There are some serious contraindications and warnings associated with Mounjaro, and medical screening and follow-up are important.
There is a boxed warning about thyroid C-cell tumors in the animal studies for Tirzepatide. The possible occurrence of these tumors, such as medullary thyroid carcinoma (MTC), in humans due to the use of Mounjaro has not been determined.
Mounjaro is not recommended for use in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other factors that may be important in the clinical setting include:
- Pancreatitis.
- Severe hypoglycemia, especially due to insulin or insulin secretagogues.
- Serious hypersensitivity reactions.
- Acute kidney injury due to hypovolemia.
- Severe gastrointestinal reactions.
- Gallbladder disease.
- Changes or complications involving diabetic retinopathy in some patients.
Can Mounjaro Cause Hypoglycemia?
Some medicines (including insulin and sulfonylureas) or taking Mounjaro with other insulin supplements may increase the risk of low blood sugar. Mounjaro at Enfield Royal Clinic in Islamabad itself is working in glucose-dependent pathways, however, it is the combination of medications that is important.
Insulin or insulin secretagogue users might need insulin dose adjustments when starting tirzepatide.
Symptoms of hypoglycemia may be sweating or trembling, hunger, dizziness, weakness, confusion, or fast heart rate. Those taking more than one glucose lowering medication should be provided specific instruction on how to monitor and treat hypoglycemia.
Patients Not Appropriate For Mounjaro
Mounjaro may not be suitable for all individuals and medical history will be closely reviewed prior to treatment. Patients should inform their health care provider about their medications and medical history, as well, before beginning treatment if they have:
- A personal or family history of medullary thyroid carcinoma.
- MEN 2
- Previous severe allergic reaction to tirzepatide.
- Pancreatic problems.
- Major gastrointestinal disease or major gastroparesis.
- Diabetic retinopathy.
- Kidney problems or a risk of dehydration.
- Gallbladder problems.
- Pregnancy, plans for pregnancy, or breastfeeding.
- An upcoming procedure requiring anesthesia or deep sedation.
The Bottom Line!
While Mounjaro can be an effective treatment for certain individuals with type 2 diabetes, its suitability may depend on a person’s health, medications, treatment goals, and medical evaluation. Patients in Islamabad who are interested in using Mounjaro injection to manage diabetes should consult with a healthcare provider who is qualified to treat diabetes for advice about their HbA1c, blood sugar readings, current medications, medical history, possible side effects, and future treatment goals.
